Colgate-Palmolive (NYSE:CL - Get Free Report) was downgraded by StockNews.com from a "buy" rating to a "hold" rating in a research note issued to investors on Thursday.
A number of other equities research analysts have also commented on the company. Stifel Nicolaus lowered Colgate-Palmolive from a "buy" rating to a "hold" rating and dropped their target price for the company from $105.00 to $101.00 in a research report on Monday, October 28th. Wells Fargo & Company cut their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research note on Tuesday. JPMorgan Chase & Co. boosted their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a research report on Friday, October 11th. Piper Sandler lowered their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a report on Monday. Finally, TD Cowen reduced their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $103.63.
Read Our Latest Research Report on Colgate-Palmolive
Colgate-Palmolive Stock Performance
CL stock remained flat at $87.39 during midday trading on Thursday. The company had a trading volume of 5,063,919 shares, compared to its average volume of 4,441,603. The firm has a 50-day simple moving average of $92.76 and a two-hundred day simple moving average of $98.15. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The firm has a market cap of $71.40 billion, a PE ratio of 25.04, a PEG ratio of 3.31 and a beta of 0.44.
Insider Activity at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.34% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Colgate-Palmolive
Several institutional investors have recently bought and sold shares of CL. Coldstream Capital Management Inc. grew its position in Colgate-Palmolive by 2.1% during the second quarter. Coldstream Capital Management Inc. now owns 10,709 shares of the company's stock worth $1,039,000 after buying an additional 221 shares during the period. MGO One Seven LLC increased its stake in Colgate-Palmolive by 17.5% in the 2nd quarter. MGO One Seven LLC now owns 9,066 shares of the company's stock valued at $880,000 after purchasing an additional 1,348 shares in the last quarter. LPL Financial LLC raised its holdings in Colgate-Palmolive by 4.6% during the second quarter. LPL Financial LLC now owns 666,793 shares of the company's stock worth $64,706,000 after purchasing an additional 29,494 shares during the last quarter. Bahl & Gaynor Inc. boosted its position in Colgate-Palmolive by 0.7% during the second quarter. Bahl & Gaynor Inc. now owns 20,361 shares of the company's stock worth $1,976,000 after purchasing an additional 144 shares in the last quarter. Finally, Achmea Investment Management B.V. grew its holdings in Colgate-Palmolive by 272.9% in the second quarter. Achmea Investment Management B.V. now owns 268,493 shares of the company's stock valued at $26,054,000 after purchasing an additional 196,498 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.
About Colgate-Palmolive
(
Get Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
